Our next petition is PE1619, which calls on the Scottish Parliament to urge the Scottish Government to make continuous glucose monitoring sensors, such as FreeStyle Libre, available on prescription to all patients with type 1 diabetes. As members will recall, the petition was also considered as part of our fact-finding visit to Dumfries and Galloway earlier this month. Do members have any comments or suggestions for further action based on the fact-finding visit?
Official Report · Committee
Continued Petitions
Diabetes (Continuous Glucose Monitoring Sensors) (PE1619)
Speakers
Choose an MSP to read only their contributions- Johann Lamont Lab 5
- Michelle Ballantyne Con 3
- Brian Whittle Con 1
- Rona Mackay SNP 1
The record
10 contributionsI sit on the cross-party group on diabetes, which sat on Tuesday this week. I discovered that, apparently, the sensor is now available and the Government will make it available on the NHS. I would like clarification that that is the case, because it seems to be a very recent development.
When we met the consultant, it was clear that the sensor was available on the NHS; the problem is the quantity that are available. The allocations for this year on the NHS are quite small. We heard that NHS Dumfries and Galloway had only four. The issue is not that the device is not available on the NHS; it is about the equitable availability of it. For me, that is part of the issue, because we are seeing a selective process.
As the consultant made clear at the meeting, he had to choose four people—he chose four children—to get the sensor out of the 12 who were suitable for it. There is no difference between them in general terms, but the difference that the device would make to their lives is enormous. It fundamentally transforms a child’s life in terms of their activities and how they can partake in normal life alongside their classmates. For me, if we are to be honest about equity, fairness and all the rest of it, we need to explore the restriction on numbers.
We also need to find out whether the funding for the equipment has been committed to the health board. It does not appear to have trickled down, because, when we were in Dumfries and Galloway, we heard that the board had not received it. I think that it was committed for 2017-18, and we are three quarters of the way through 2017, so it would be interesting to know where the funding is. We might have been overtaken by events, as Brian Whittle says, and it may now have been agreed, but we need clarification.
We will ask the Scottish Government to provide further evidence at a meeting, and the petitioner can respond to that. There are particular questions around equity of access. Also, if the funding has been allocated, what monitoring has been done of that money being put into the system?
Could I ask that we look at one other thing as well, convener? One of the conflicting pieces of evidence was around cost. We were given some pharmaceutical information on costs that suggested that a glucose monitoring sensor was no more expensive than the traditional injecting and blood sampling. However, when we spoke to the consultant, he suggested that it was the other way round. It is important that the committee understands the underpinning cost of the policy. It is a no-brainer if the device costs the same or less; it becomes slightly more complicated if there is a significant upcost to it, because that budget will have to be found. It is important that we understand what the cost is, because that will alter the conversation that we have.
We would be concerned if it were a matter of rationing, as you pointed out. If someone is entitled to it, they are entitled to it.
No, I am not talking about whether we think that everybody who is entitled to it should have it—I think that they should. The issue is that the conversation about how we make that happen will be different if there is a deficit in the costing. We need to understand whether there is a deficit in the costing or whether it is like for like.
We can ask the Scottish Government about that as well.
Are we agreed that we will invite the Scottish Government to give evidence at a future meeting, to which the petitioner will be able to respond?
Members indicated agreement.
I echo Angus MacDonald’s comments and express the committee’s thanks to everyone who participated in the fact-finding visit in relation to both the A75 and the question of diabetes continuous glucose monitoring sensors. Unfortunately, I was unable to attend the visit, which I understand was very informative and interesting. We are grateful to all the people who gave their time to engage with the committee and hope that they found it useful, too. It looks as though it is a good model for the committee’s future activities.
In this meeting
Everything on 21 Sep 2017 →- 09:00 Decision on Taking Business in Private Procedure · 1
- 09:00 New Petitions Petitions · 13
- 09:00 New Petitions Petitions · 11
- 09:00 New Petitions Petitions · 17
- 09:00 New Petitions Petitions · 11
- 09:00 New Petitions Petitions · 15
- 09:00 New Petitions Petitions · 10
- 09:45 New Petitions Petitions · 14
- 10:00 Continued Petitions Petitions · 13
- 10:00 Continued Petitions Petitions · 4
- 10:15 Continued Petitions Petitions · 5
- 10:15 Continued Petitions Petitions · 10
- 10:15 Continued Petitions Petitions · 11
- 10:30 Continued Petitions Petitions · 18
- 10:30 Continued Petitions Petitions · 10
- 10:30 Continued Petitions Petitions · 7
- 10:45 Continued Petitions Petitions · 17
- 10:45 Continued Petitions Petitions · 8
- 10:45 Continued Petitions Petitions · 6
The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.